394 related articles for article (PubMed ID: 28186287)
21. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
22. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Kitagawa S; Zenke Y; Taki T; Aokage K; Sakai T; Shibata Y; Izumi H; Nosaki K; Umemura S; Matsumoto S; Yoh K; Sakamoto N; Sakashita S; Kojima M; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2024 Feb; 188():107453. PubMed ID: 38160515
[TBL] [Abstract][Full Text] [Related]
24. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of Solid and Micropapillary Components in Invasive Lung Adenocarcinomas Measuring ≤3 cm.
Matsuoka Y; Yurugi Y; Takagi Y; Wakahara M; Kubouchi Y; Sakabe T; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2016 Sep; 36(9):4923-30. PubMed ID: 27630350
[TBL] [Abstract][Full Text] [Related]
26. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.
Warth A; Muley T; Kossakowski C; Stenzinger A; Schirmacher P; Dienemann H; Weichert W
J Thorac Oncol; 2015 Apr; 10(4):638-44. PubMed ID: 25634008
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
[TBL] [Abstract][Full Text] [Related]
33. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
[TBL] [Abstract][Full Text] [Related]
34. Clinical usefulness of the 3-tier classification according to the proportion of morphological patterns for patients with pathological stage I invasive lung adenocarcinoma.
Osawa J; Shimada Y; Maehara S; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Matsubayashi J; Ikeda N
Gen Thorac Cardiovasc Surg; 2021 Jun; 69(6):943-949. PubMed ID: 33385289
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.
Tsubokawa N; Mimae T; Miyata Y; Sasada S; Yoshiya T; Kushitani K; Takeshima Y; Murakami S; Yokose T; Ito H; Nakayama H; Okada M
Jpn J Clin Oncol; 2016 Nov; 46(11):1015-1021. PubMed ID: 27566971
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
37. Current readings: pathology, prognosis, and lung cancer.
Suh JH
Semin Thorac Cardiovasc Surg; 2013; 25(1):14-21. PubMed ID: 23800525
[TBL] [Abstract][Full Text] [Related]
38. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
[TBL] [Abstract][Full Text] [Related]
39. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
40. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]